GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » EBIT

Hamilton Thorne (TSX:HTL) EBIT : C$-0.32 Mil (TTM As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne EBIT?

Hamilton Thorne's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was C$-0.08 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.32 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Hamilton Thorne's annualized ROC % for the quarter that ended in Mar. 2024 was -0.32%. Hamilton Thorne's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -0.97%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Hamilton Thorne's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -0.13%.


Hamilton Thorne EBIT Historical Data

The historical data trend for Hamilton Thorne's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne EBIT Chart

Hamilton Thorne Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 2.89 5.92 3.31 0.35

Hamilton Thorne Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 -0.47 -0.99 1.22 -0.08

Competitive Comparison of Hamilton Thorne's EBIT

For the Medical Devices subindustry, Hamilton Thorne's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamilton Thorne's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hamilton Thorne's EV-to-EBIT falls into.



Hamilton Thorne EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamilton Thorne  (TSX:HTL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Hamilton Thorne's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-0.228 * ( 1 - -66.27% )/( (118.947 + 119.74)/ 2 )
=-0.3790956/119.3435
=-0.32 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Hamilton Thorne's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.32/( ( (13.649 + max(18.417, 0)) + (14.6 + max(19.619, 0)) )/ 2 )
=-0.32/( ( 32.066 + 34.219 )/ 2 )
=-0.32/33.1425
=-0.97 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(11.111 + 19.377 + 2.869) - (14.599 + 0.341 + 0)
=18.417

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(12.966 + 18.179 + 3.756) - (14.952 + 0.33 + 3.5527136788005E-15)
=19.619

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Hamilton Thorne's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=-0.317/246.665
=-0.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamilton Thorne EBIT Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamilton Thorne (TSX:HTL) Business Description

Traded in Other Exchanges
Address
100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Executives
Robert J Potter Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines